SubscribeLogin
Published

Drugmaker shares drop after RFK Jr. tapped to lead HHS

  • Shares in vaccine makers and healthcare firms dropped sharply after Robert F Kennedy Jr was tapped as US Health Secretary, raising investor concerns about the sector.
  • Kennedy has stated he will use the position to crack down on 'Big Pharma,' which has led to fears of increased anti-vaccine rhetoric.
  • Health policy experts believe this could deter Americans from receiving Covid shots and routine immunizations, as noted by former CDC Director Dr. Richard Besser.
Insights by Ground AI
Does this summary seem wrong?
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • 50% of the sources are Center
50% Center
Factuality

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

Sources are mostly out of (0)

Similar News Topics

Donald TrumpDonald Trump
Robert F. Kennedy Jr.Robert F. Kennedy Jr.
BusinessBusiness
US EconomyUS Economy
North American EconomyNorth American Economy
AmericasAmericas
Stock MarketsStock Markets
Trending Topics
App Store IconPlay Store Icon
CompanyAboutHistoryMissionBlogTestimonialsGroup SubscriptionsSubscribeGiftFree TrialCareersAffiliates
HelpHelp CenterFAQContact UsFor Educators/LibrariesMedia Bias RatingsOwnership and Factuality RatingsReferral CodeNews SourcesTopics
ToolsAppBrowser ExtensionDaily NewsletterBlindspot Report NewsletterBurst Your Bubble NewsletterTimelines
DonatePrivacy PolicyManage CookiesTerms and Conditions
© 2024 Snapwise Inc
News
For You
Search
BlindspotLocal